Sign inJoin waitlistJoin the waitlist

Kristin Higgins

Physician · Atlanta Cancer Hospital City of Hope

Credentials: · · · ·

History

Atlanta Cancer Hospital City of Hope
2024–Present

Radiation Oncology
Duke University Hospital
2007–2011
Preliminary or Transitional Year
2006–2007
Tulane University School of Medicine
2002–2006

Research

An update on larynx cancer
Review · Current Anthropology · 2017 · 577 citations
Survival After Sublobar Resection versus Lobectomy for Clinical Stage IA Lung Cancer: An Analysis from the National Cancer Data Base
Journal of Thoracic Oncology · 2015 · 198 citations
Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement
Radiotherapy and Oncology · 2020 · 167 citations

Nabil Saba
43 papers
Walter Curran
40 papers
JB
Jonathan Beitler
39 papers
Jeff Bradley
34 papers
Suresh Ramalingam
31 papers
Dong Shin
30 papers
Conor Steuer
23 papers · 1 as a fellow
Taofeek Owonikoko
23 papers
Sibo Tian
22 papers · 12 as a resident
Andrew Miller
18 papers
CS
Charles Simone
18 papers
Pretesh Patel
18 papers

Grants

Defining the Role of Twice-Daily Thoracic Radiotherapy in Limited-Stage SCLC in the Immunotherapy Era: A Trial Integration Approach
National Cancer Institute · R21
PI · $407.9K · Johns Hopkins University
2026–2028
Winship National Clinical Trials Network Lead Academic Participating Site
National Cancer Institute · UG1
Contact PI · $3.6M · Emory University
2019–2025

Clinical trials

Palliative Radiotherapy With Lurbinectedin in Patients With Extensive Stage Small Cell Lung Cancer
Principal investigator · Recruiting · Phase 1
Emory University
2022–2027
Prospective Study of Intensity-Modulated Proton Therapy (IMPT) for Small Cell Lung Cancer
Principal investigator · Recruiting
Emory University
2020–2028
Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC)
Principal investigator · Active not recruiting · Phase 3
National Cancer Institute (NCI)
2019–2029
Fludeoxyglucose F-18-PET in Planning Lung Cancer Radiation Therapy
Principal investigator · Completed · Phase 1
Emory University
2018–2019